Mechanical vagus nerve stimulation - A new adjunct in sepsis prophylaxis and treatment?

Critical Care Medicine

Volumn 35, Issue 12, 2007, Pages 2868-2869

  Bauhofer, Artur ^a   Torossian, Alexander ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Animal model; Cytokines; Immune neuroendocrine network; Inflammation; Sepsis; Vagus nerve stimulation

Indexed keywords

CYTOKINE; INTERLEUKIN 10;

CAROTID SINUS MASSAGE; CYTOKINE PRODUCTION; EDITORIAL; HUMAN; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SEPSIS; SURVIVAL RATE; VAGUS NERVE; VAGUS NERVE STIMULATION;

EID: 36448982536     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000288083.32202.DC     Document Type: Editorial

References (14)

1. Borovikova LV, Ivanova S, Zhang M, et al: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405:458-462
2. Tracey KJ: Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 2007; 117:289-296
3. Wang H, Liao H, Ochani M, et al: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10:1216-1221
4. Van Gilder TJ, Remington PL, Fiore MC: The direct effects of nicotine use on human health. Wis Med J 1997; 96:43-48
5. Wu R, Dong W, Cui X, et al: Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007; 245:480-486
6. Pavlov VA, Ochani M, Yang LH, et al: Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007; 35:1139-1144
7. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, et al: The vagus nerve: A tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 2006; 131:1122-1130
8. Guarini S, Altavilla D, Cainazzo MM, et al: Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003; 107:1189-1194
9. Huston JM, Gallowitsch M, Ochani M, et al: Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007; 35:2762-2768
10. Privitera MD, Welty TE, Ficker DM, et al: Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev 2002; CD002896
11. Ben-Menachem E: Vagus nerve stimulation, side effects, and long-term safety. J Clin Neurophysiol 2001; 18:415-418
12. Corcoran C, Connor TJ, O'Keane V, et al: The effects of vagus nerve stimulation on pro-and anti-inflammatory cytokines in humans: A preliminary report. Neuroimmunomodulation 2005; 12:307-309
13. Kirchner A, Stefan H, Bastian K, et al: Vagus nerve stimulation suppresses pain but has limited effects on neurogenic inflammation in humans. Eur J Pain 2006; 10:449-455
14. Bauhofer A, Plaul U, Torossian A, et al: Perioperative prophylaxis with granulocyte colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery: A randomized, controlled trial. Surgery 2007; 141:501-510